Clinical Trial Update: Efficacy and Safety of the Combination of Aliskiren (300 mg) and Amlodipine (10 mg) Compared to Amlodipine (10 mg) Monotherapy in Patients With Moderate to Severe Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the efficacy and safety of combining aliskiren with amlodipine versus amlodipine alone in patients with moderate to severe hypertensi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Aliskiren (Aliskiren)
• Amlodipine (amlodipine)
• NORVASC (amlodipine besylate)
• Tekturna (aliskiren)

Snippet

Sponsor: Novartis | Conditions: Moderate to Severe Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2011-06-27